Prescription drug · NDA AUTHORIZED GENERIC
Alprazolam XR (alprazolam) NDC 59762-0066
Alprazolam 2 mg/1 · Tablet, Extended release · Oral · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59762-0066-1 | 59762006601 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0066-1)Marketed from Jan 17, 2003 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Alprazolam XRSuffix: XR
- Generic name (nonproprietary)
- alprazolam
- Active ingredients
- Alprazolam — 2 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Mylan Pharmaceuticals Inc.
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 021434
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 59762-0066_70f0098e-50b5-4e61-b4e0-141a55d92267SPL ID 70f0098e-50b5-4e61-b4e0-141a55d92267SPL set ID 1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3RxCUI 433798, 433799, 433800, 433801UNII YU55MQ3IZY
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459762006601followed by a unit qualifier and the quantityPackage 59762-0066-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Alprazolam XR is indicated for the treatment of panic disorder with or without agoraphobia, in adults. Alprazolam XR is a benzodiazepine indicated for the treatment of panic disorder with or without agoraphobia, in adults. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 021434
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Alprazolam XRalprazolam | Alprazolam 1 mg/1 | Tablet, Extended releaseOral | Mylan Pharmaceuticals Inc. | 59762-0059 |
| Alprazolam XRalprazolam | Alprazolam .5 mg/1 | Tablet, Extended releaseOral | Mylan Pharmaceuticals Inc. | 59762-0057 |
| Alprazolam XRalprazolam | Alprazolam 3 mg/1 | Tablet, Extended releaseOral | Mylan Pharmaceuticals Inc. | 59762-0068 |
| Xanax XRalprazolam | Alprazolam 2 mg/1 | Tablet, Extended releaseOral | Viatris Specialty LLC | 58151-505 |
| Xanax XRalprazolam | Alprazolam 3 mg/1 | Tablet, Extended releaseOral | Viatris Specialty LLC | 58151-506 |